These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Implantable cardioverter/defibrillators (ICDs). Med Lett Drugs Ther; 1994 Sep; 36(932):86-8. PubMed ID: 8084305 [No Abstract] [Full Text] [Related]
26. Twiddler's syndrome in a patient with a single-chamber implantable cardioverter defibrillator. Czepiel A; Makowska E; Kulakowski P Europace; 2008 Mar; 10(3):366. PubMed ID: 18245200 [No Abstract] [Full Text] [Related]
27. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. Bardy GH; Yee R; Jung W J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117 [TBL] [Abstract][Full Text] [Related]
28. Discrimination when dual-chamber termination fails: a new paradigm for ICDs? Mark Estes NA J Cardiovasc Electrophysiol; 2006 Jul; 17(7):702-4. PubMed ID: 16836662 [No Abstract] [Full Text] [Related]
30. A novel solution for repeated migration of an implantable cardiac defibrillator. Sheikh AM; Raza I; Sporton SC; Lall KS J Thorac Cardiovasc Surg; 2010 Feb; 139(2):499-501. PubMed ID: 19660286 [No Abstract] [Full Text] [Related]
31. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system]. Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649 [TBL] [Abstract][Full Text] [Related]
32. [Implantable defibrillators in the management of malignant ventricular tachyarrhythmias. Experience at the Arrhythmia National Center]. Asenjo R; Oyarzún R; González M; Morales P; Zamorano J; Brunet L; Morris R; Ortiz M Rev Med Chil; 1998 Jul; 126(7):803-13. PubMed ID: 9830773 [TBL] [Abstract][Full Text] [Related]
33. A focus on when and when not to use antiarrhythmic drugs in treating ventricular arrhythmias and indications for the use of automatic implantable cardioverter-defibrillators. Aronow WS Geriatrics; 2008 Aug; 63(8):20-8. PubMed ID: 18672953 [TBL] [Abstract][Full Text] [Related]
34. Fatal outcome from inappropriate defibrillation. Dimitri H; John B; Young GD; Sanders P Europace; 2007 Nov; 9(11):1059-60. PubMed ID: 17827163 [TBL] [Abstract][Full Text] [Related]
35. Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators: Sweeney MO Pacing Clin Electrophysiol; 2004 Sep; 27(9):1292-305. PubMed ID: 15461721 [No Abstract] [Full Text] [Related]
36. [Therapy of ventricular tachyarrhythmia with implantable cardioverters/defibrillators--mortality and complications using epicardial electrodes]. Wietholt D; Block M; Isbruch F; Böcker D; Hammel D; Borggrefe M; Scheld HH; Breithardt G Z Kardiol; 1993 Mar; 82(3):150-61. PubMed ID: 8475651 [TBL] [Abstract][Full Text] [Related]
37. Early MRI scanning of device patients-not so fast. Roguin A Pacing Clin Electrophysiol; 2013 Dec; 36(12):1447-8. PubMed ID: 23827057 [No Abstract] [Full Text] [Related]
38. An 82-year-old man with an implantation of a CPI Ventak AV II DR device for sustained ventricular tachycardia. Marieb MA; Schwartz KV Pacing Clin Electrophysiol; 2003 Nov; 26(11):2209. PubMed ID: 14622330 [No Abstract] [Full Text] [Related]
39. Reel syndrome in an ICD with DF4 connector. Wollmann CG Herzschrittmacherther Elektrophysiol; 2014 Sep; 25(3):206-8. PubMed ID: 24990537 [TBL] [Abstract][Full Text] [Related]